Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
---|---|---|---|---|---|---|
2012-11-05 | Kalvista Pharmaceuticals (UK) | £2.4 million (€ 3 million) | grant | Biomedical Catalyst Fund (UK) | Ophtalmological diseases | Grant |
2012-11-05 | Immunocore (UK) | £2.4 million (€ 3 million) | grant | Biomedical Catalyst Fund (UK) | Cancer - Oncology | Grant |
2012-11-05 | Intelligent Fingerprinting (UK) | £425,000 (€ 533 350) | grant | Biomedical Catalyst Fund (UK) | Technology - Services | Grant |
2012-11-05 | Modern Biosciences (UK) | £1.6 million (€ 2 million) | grant | Biomedical Catalyst Fund (UK) | Grant | |
2012-11-05 | PsiOxus Therapeutics (UK) | £1.7m (€2.1 million) | grant | Biomedical Catalyst Fund (UK) | Cancer - Oncology | Grant |
2012-11-05 | Sentinel Oncology (UK) | £1.8m (€ 2.2 million) | grant | Biomedical Catalyst Fund (UK) | Cancer - Oncology | Grant |
2012-11-04 | Discuva (UK) | £1.62 million (€ 2 million) | grant | Biomedical Catalyst Fund (UK) - New Wave Ventures LLP (UK) | Infectious diseases | Grant |
2012-11-02 | Dilaforette (Sweden) | SEK 2.85 million (€ 0.3 million) | grant | Vinnova, Swedish Governmental Agency for Innovation Systems (Sweden) | Infectious diseases | Grant |
2012-11-01 | ValiRx (UK) | £2.03 million (€2.5 million) | Cancer - Oncology | Fundraising | ||
2012-10-31 | Haemostatix (UK) | £1.4 million (€1.78 million) + £800,000 | award | Wellcome Trust (UK) Albion Ventures (UK) Catapult Venture Managers (UK) Spark Ventures (UK) Esperante (UK) Nesta (UK) the Lachesis Fund The University of Leicester (UK) private share-holders (UK) |
Hemostasis | Subvention |
2012-10-31 | Phenex Pharmaceuticals (Germany) | € 5 million | EVP Capital Partners (Germany) | Autoimmune diseases – Immunological diseases - Liver diseases | Fundraising | |
2012-10-30 | Complix (Belgium) | € 1.9 Million | grant | Flemish agency for Innovation by Science and Technology (IWT) (Belgium) |
Cancer - Oncology - CNS diseases - Inflammatory diseases - Metabolic diseases | Grant |
2012-10-25 | AMP Therapeutics (Germany) | € 1.7 million | grant | SAB State Bank of Saxony (Germany) | Infectious diseases | Grant |
2012-10-24 | Nanobiotix (France) | € 20 million | IPO | Cancer - Oncology | IPO | |
2012-10-24 | Orizon (Spain) | € 1.1 million | grant | Ministry of Economy and Competitiveness (Spain) | Cancer - Oncology | Grant |
2012-10-23 | 4SC (Germany) | € 600,000 | grant | Cancer - Oncology | Grant | |
2012-10-23 | Vaccibody (Norway) | €2 million | grant | Norwegian Research Council (Norway) | Cancer - Oncology - Infectious diseases | Grant |
2012-10-22 | Summit (UK) | £4.0 million (€4.9 million) | award | Wellcome Trust (UK) | Rare diseases - Neuromuscular diseases - Infectious diseases | Subvention |
2012-10-22 | Pharma Two B (Israel) | $8 million | financing round | Neurodegenerative diseases | Fundraising | |
2012-10-19 | Redx Pharma (UK) | £4.7 million (€5.7 million) | grant | Regional Growth Fund (RGF) (UK) |
Infectious diseases | Grant |